Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026)
Pharma-Bio Serv (PBSV) posted Capital Expenditures of $2321.0 for Q2 2026, down 3.73% on a QoQ basis from $2411.0 in Q1 2026, and down 45.49% year-over-year from $4258.0 in Q2 2025.
Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Capital Expenditures history runs 17 years deep, the most recent figure standing at $2321.0 for Q2 2026.
- Quarterly Capital Expenditures fell 45.49% year-over-year to $2321.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $7118.0 (down 95.64% YoY) and the FY2025 annual result came in at $6644.0, down 95.84% from the prior year.
- Capital Expenditures was $2321.0 for Q2 2026 at Pharma-Bio Serv, down from $2411.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $157015.0 in Q4 2024 and bottomed at -$1580.0 in Q4 2023.
- A 5-year average of $13175.9 and a median of $2087.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures sank 113.02% — and 2024, when it surged 10037.66%.
- Pharma-Bio Serv's Capital Expenditures stood at $12137.0 in 2022, then plunged by 113.02% to -$1580.0 in 2023, then jumped by 10037.66% to $157015.0 in 2024, then plunged by 99.78% to $350.0 in 2025, then surged by 563.14% to $2321.0 in 2026.
- Business Quant data shows PBSV's Capital Expenditures at $2321.0 in Q2 2026, $2411.0 in Q1 2026, and $350.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.19 Bn | 24.88 Bn | 662.02 Mn | 1.75 Mn |
| 2 | BrightSpring Health Services | 14.68 Bn | 13.78 Bn | 482.22 Mn | 21.54 Mn |
| 3 | Healthequity | 8.43 Bn | 8.16 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 5.97 Bn | 5.65 Bn | 154.23 Mn | 83,000.00 |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn | 118,000.00 |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | 56.00 Mn |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 15.33 Mn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | -6.65 Mn |
| 9 | Privia Health | 3.11 Bn | 2.70 Bn | - | -978,000.00 |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | 2,321.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2,321.00 |
| Apr 30, 2026 | 2,321.00 |
| Jan 31, 2026 | 2,411.00 |
| Jan 31, 2026 | 2,411.00 |
| Oct 31, 2025 | 350.00 |
| Oct 31, 2025 | 350.00 |
| Jul 31, 2025 | 2,036.00 |
| Jul 31, 2025 | 2,036.00 |
| Apr 30, 2025 | 4,258.00 |
| Apr 30, 2025 | 4,258.00 |
| Oct 31, 2024 | 157,015.00 |
| Oct 31, 2024 | 157,015.00 |
| Jul 31, 2024 | 1,908.00 |
| Jul 31, 2024 | 1,908.00 |
| Jan 31, 2024 | 820.00 |
| Jan 31, 2024 | 820.00 |
| Oct 31, 2023 | -1,580.00 |
| Oct 31, 2023 | -1,580.00 |
| Apr 30, 2023 | 764.00 |
| Apr 30, 2023 | 764.00 |